Clinical Trial Update: Observational Registry on the HARPOON Device [NA]

View source ↗

Summary

Observational registry update for the HARPOON device study (terminated) with results posted in 2024; focus on severe degenerative mitral regurgitation due to mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• HARPOON

Snippet

Sponsor: Edwards Lifesciences | Conditions: Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse | NA | Status: TERMINATED | Results posted: 2024-01-29